Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery
Author(s) -
Gaetano Pierpaolo Privitera,
Paolo Scarpellini,
G Ortisi,
Gianlucca Gonçalves Nicastro,
Roberto Nicolin,
Fausto de Lalla
Publication year - 1991
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.35.1.208
Subject(s) - mezlocillin , cefoxitin , medicine , cefotetan , cefazolin , clostridium difficile , cephalosporin , cefoperazone , antibiotics , ceftriaxone , surgery , diarrhea , antibiotic associated diarrhea , gastroenterology , microbiology and biotechnology , piperacillin , staphylococcus aureus , imipenem , antibiotic resistance , genetics , bacteria , pseudomonas aeruginosa , biology
A total of 108 volunteers undergoing an elective surgical procedure were randomly given a single 2-g intravenous prophylactic dose of either a cephalosporin or mezlocillin. Stool samples were cultured for Clostridium difficile the day before the operation and later on postoperative days 4, 7, and 14. C. difficile was detected in 23.0% of patients who received a cephalosporin (cefoxitin, 8.3%; cefazolin, 14.3%; cefotetan, 20.0%; ceftriaxone, 25.0%; cefoperazone, 43.7%), in 3.3% of patients given mezlocillin, and in none of 15 control volunteers given no antimicrobial agent. No patient experienced diarrhea.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom